2018-12-19T10:47:30Zhttp://prdfedo2.unil.ch/oaiprovider/oai:serval.unil.ch:BIB_EB4FE1C2D1D72018-12-15T02:02:41Zopenairedocumentsurnservalserval:BIB_EB4FE1C2D1D7Novel technologies and emerging biomarkers for personalized cancer immunotherapy.10.1186/s40425-016-0107-326788324YuanJ.authorHegdeP.S.authorClynesR.authorFoukasP.G.authorHarariA.authorKleenT.O.authorKvistborgP.authorMaccalliC.authorMaeckerH.T.authorPageD.B.authorRobinsH.authorSongW.authorStackE.C.authorWangE.authorWhitesideT.L.authorZhaoY.authorZwierzinaH.authorButterfieldL.H.authorFoxB.A.authorarticlereview2016Journal For Immunotherapy of Cancer2051-14262051-1426journal43eng60_publishedpeer-reviewedhttps://serval.unil.ch/notice/serval:BIB_EB4FE1C2D1D7https://serval.unil.ch/resource/serval:BIB_EB4FE1C2D1D7.P001/REF.pdfhttp://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_EB4FE1C2D1D77Copying allowed only for non-profit organizations